- Home
- EPM vs STTK Comparison
EPM vs STTK Comparison
Compare EPM & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPM
- STTK
- Stock Information
- Founded
- EPM 2003
- STTK 2016
- Country
- EPM United States
- STTK United States
- Employees
- EPM N/A
- STTK N/A
- Industry
- EPM Oil & Gas Production
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- EPM Energy
- STTK Health Care
- Exchange
- EPM Nasdaq
- STTK Nasdaq
- Market Cap
- EPM 171.8M
- STTK 173.6M
- IPO Year
- EPM 1996
- STTK 2020
- Fundamental
- Price
- EPM $5.48
- STTK $3.68
- Analyst Decision
- EPM Strong Buy
- STTK Strong Buy
- Analyst Count
- EPM 1
- STTK 3
- Target Price
- EPM $8.25
- STTK $10.67
- AVG Volume (30 Days)
- EPM 287.7K
- STTK 152.2K
- Earning Date
- EPM 09-10-2024
- STTK 11-07-2024
- Dividend Yield
- EPM 8.93%
- STTK N/A
- EPS Growth
- EPM N/A
- STTK N/A
- EPS
- EPM 0.12
- STTK N/A
- Revenue
- EPM $85,877,000.00
- STTK $4,123,999.00
- Revenue This Year
- EPM N/A
- STTK $164.45
- Revenue Next Year
- EPM $22.21
- STTK N/A
- P/E Ratio
- EPM $44.79
- STTK N/A
- Revenue Growth
- EPM N/A
- STTK 380.09
- 52 Week Low
- EPM $4.59
- STTK $1.33
- 52 Week High
- EPM $7.98
- STTK $11.76
- Technical
- Relative Strength Index (RSI)
- EPM 59.86
- STTK 51.99
- Support Level
- EPM $4.59
- STTK $3.37
- Resistance Level
- EPM $5.49
- STTK $3.94
- Average True Range (ATR)
- EPM 0.16
- STTK 0.22
- MACD
- EPM 0.04
- STTK 0.07
- Stochastic Oscillator
- EPM 87.80
- STTK 61.54
About EPM Evolution Petroleum Corporation Inc.
Evolution Petroleum Corp is an independent oil and gas company operating in the US. It is engaged primarily in the acquisition, exploitation, and development of properties for the production of crude oil and natural gas, onshore in the United States. The company's revenues are primarily generated from its crude oil, natural gas and NGL production from the Jonah Field in Sublette County, Wyoming; the Williston Basin in North Dakota; the Barnett Shale located in North Texas; the Hamilton Dome Field in Wyoming; and the Delhi Field in Northeast Louisiana. The revenue generated by the company includes royalty, mineral and working interests.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.